Article
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?
31 Dec 2010
Abstract excerpt
BRAFV600E is a constitutively active onco-kinase and is the most common genetic alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well, albeit at a lower frequency. The BRAFV600E mutation in some studies has been significantly associated with extra-thyroidal extension, metastases, recurrence, and mortality in patients with PTC. A recent genome-wide expression profiling...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
